JPMorgan analyst, Robbie Marcus, reiterated his Overweight rating on shares of iRhythm Technologies (NASDAQ: IRTC) noting that the company has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE